Diagnostics, animal health, academic research, nutraceuticals, contract testing, biobanks, and similar work still have documents to control, studies to run, and inspections to pass. The usual options are software built for a different industry, or an enterprise platform with an implementation a lean team can't absorb. LabRelations takes a different approach. Our CTMS and QMS platforms are designed to fit how your team actually works - configurable enough to match your processes, light enough to go live without a year-long project. There's still setup, and our team is with you through it - but we've done the hard work upfront so you're running sooner, with less complexity to manage. Both platforms are built to be intuitive, keeping operations and quality teams productive and inspection-ready under the GxP, ISO, and 21 CFR Part 11 requirements that apply to you.
If you run studies, manage quality, or both, that means capable software without forcing your work into someone else's template.
LabRelations Clinical Platform and Quality Platform are built for regulated work - even when your industry isn't on the usual list.
Yes. The same CTMS and QMS that sponsors and CROs use are configurable for diagnostics, animal health, academic research, nutraceuticals, contract testing, biobanks, and similar regulated environments. You get study operations, documents, training, deviations, and CAPA without adopting a pharma-shaped workflow you don't need.
QMS for documents, SOPs, deviations, change control, training, supplier qualification, and risk. CAPAs run from open to close in one place. When an SOP changes, the right people get re-trained automatically. If you also run studies or investigations, CTMS replaces spreadsheets and email with a single source of truth for studies, sites, subjects, and milestones - inspection-ready under GCP and 21 CFR Part 11 when those apply.
A mix of people who've worked in regulated operations and quality, backed by technical people for configuration needs inside the platform itself. They've seen quality systems outside the usual pharma and device path, and they don't expect your processes to match a textbook sponsor.